Index RUT P/E - EPS (ttm) -0.74 Insider Own 1.51% Shs Outstand 192.74M Perf Week 4.18%
Market Cap 198.85M Forward P/E - EPS next Y -0.88 Insider Trans -1.31% Shs Float 189.83M Perf Month -24.69%
Income -91.17M PEG - EPS next Q -0.44 Inst Own 61.93% Short Float 15.67% Perf Quarter -11.82%
Sales 21.73M P/S 9.15 EPS this Y 10.88% Inst Trans 7.50% Short Ratio 3.47 Perf Half Y -63.93%
Book/sh 2.08 P/B 0.50 EPS next Y 45.28% ROA -16.08% Short Interest 29.75M Perf Year -69.92%
Cash/sh 0.95 P/C 1.09 EPS next 5Y 45.80% ROE -47.81% 52W Range 0.88 - 5.53 Perf YTD -25.24%
Dividend Est. - P/FCF - EPS past 5Y - ROI -20.06% 52W High -81.34% Beta 0.83
Dividend TTM - Quick Ratio 1.42 Sales past 5Y 120.04% Gross Margin -15.86% 52W Low 17.37% ATR (14) 0.11
Dividend Ex-Date - Current Ratio 1.55 EPS Y/Y TTM 87.79% Oper. Margin -1523.91% RSI (14) 41.93 Volatility 9.40% 9.25%
Employees - Debt/Eq 1.36 Sales Y/Y TTM 322.60% Profit Margin -419.62% Recom 2.77 Target Price 3.77
Option/Short Yes / Yes LT Debt/Eq 1.04 EPS Q/Q 29.93% Payout - Rel Volume 0.59 Prev Close 0.95
Sales Surprise -53.53% EPS Surprise 5.67% Sales Q/Q 17353.52% Earnings Mar 26 BMO Avg Volume 8.57M Price 1.03
SMA20 -10.58% SMA50 -18.16% SMA200 -58.68% Trades
Volume 1,184,816 Change 8.19%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-11-23 Downgrade HSBC Securities
Hold → Reduce
Dec-08-23 Upgrade Morgan Stanley
Underweight → Equal-Weight
$3 → $7
Oct-17-23 Initiated Cantor Fitzgerald
Neutral
Sep-06-23 Initiated HSBC Securities
Buy
$4.21
Jul-19-23 Upgrade BofA Securities
Neutral → Buy
$6 → $10
Jun-01-23 Upgrade Barclays
Equal Weight → Overweight
$7 → $8
Apr-28-23 Initiated JP Morgan
Overweight
$7
Mar-07-23 Initiated Robert W. Baird
Outperform
$10
Aug-05-22 Upgrade Barclays
Underweight → Equal Weight
Aug-02-22 Upgrade Raymond James
Mkt Perform → Outperform
$8
Apr-06-22 Downgrade Cowen
Outperform → Market Perform
Mar-07-22 Downgrade Barclays
Equal Weight → Underweight
$4
Nov-08-21 Reiterated Wells Fargo
Equal Weight
$25 → $16
Nov-08-21 Reiterated Wedbush
Neutral
$22 → $11
Nov-08-21 Reiterated RBC Capital Mkts
Sector Perform
$26 → $14
Nov-08-21 Reiterated Canaccord Genuity
Hold
$20 → $15
Nov-08-21 Reiterated Barclays
Equal Weight
$20 → $13
Nov-08-21 Downgrade Morgan Stanley
Equal-Weight → Underweight
$11
Nov-08-21 Downgrade Goldman
Neutral → Sell
$23 → $10
Aug-10-21 Resumed William Blair
Mkt Perform
Show Previous Ratings
Apr-16-24 02:05PM
Apr-15-24 08:15AM
Apr-13-24 04:22PM
Apr-11-24 08:30AM
08:00AM
11:33AM
Loading…
Apr-02-24 11:33AM
Mar-29-24 05:20AM
Mar-27-24 11:37AM
10:00AM
Mar-26-24 07:01AM
Mar-25-24 04:05PM
Mar-19-24 07:44AM
Mar-18-24 06:05PM
08:00AM
Mar-13-24 07:50AM
08:00AM
Loading…
Mar-11-24 08:00AM
Mar-05-24 06:56PM
Jan-27-24 07:28AM
05:27AM
Jan-10-24 06:55AM
Jan-08-24 08:00AM
Jan-04-24 03:32PM
(The Wall Street Journal) +5.84%
Jan-03-24 07:15AM
Jan-02-24 08:00AM
Dec-26-23 08:00AM
Dec-24-23 07:39AM
Dec-23-23 07:30AM
Dec-22-23 08:45AM
Dec-20-23 02:23PM
01:54PM
09:41PM
Loading…
Dec-19-23 09:41PM
Dec-18-23 04:01PM
Dec-15-23 11:14AM
Dec-11-23 05:43AM
Dec-10-23 12:02PM
Dec-09-23 11:31AM
Dec-08-23 01:45PM
(The Wall Street Journal) -40.54%
01:01PM
12:35PM
Dec-07-23 11:30AM
08:45AM
Dec-01-23 07:41AM
Nov-29-23 02:28PM
Nov-26-23 04:44PM
Nov-24-23 07:00AM
(The Wall Street Journal)
Nov-08-23 03:39PM
Nov-07-23 05:18PM
08:00AM
07:46AM
07:27AM
(Associated Press Finance)
07:00AM
Nov-04-23 08:45AM
Nov-02-23 09:37AM
Oct-30-23 08:00AM
Oct-24-23 08:00AM
Oct-17-23 09:47AM
Sep-29-23 09:00AM
Sep-20-23 07:21AM
Sep-12-23 07:00AM
05:14AM
Sep-07-23 11:30AM
Sep-05-23 04:05PM
Aug-29-23 05:25AM
Aug-28-23 08:30AM
Aug-24-23 10:15AM
Aug-16-23 07:00AM
Aug-08-23 08:25AM
07:18AM
07:00AM
07:00AM
Aug-05-23 09:40AM
Jul-27-23 11:19AM
Jul-25-23 08:00AM
Jul-22-23 06:14AM
Jul-20-23 01:14AM
Jul-19-23 12:36PM
Jun-30-23 10:15AM
Jun-29-23 09:53AM
07:45AM
Jun-21-23 07:00AM
Jun-15-23 10:00AM
Jun-08-23 11:30AM
Jun-01-23 02:09AM
May-10-23 07:57AM
May-09-23 07:10AM
07:00AM
Apr-27-23 04:05PM
Apr-24-23 03:49PM
07:30AM
Apr-13-23 02:17PM
Apr-06-23 10:15AM
08:00AM
06:30AM
Apr-02-23 09:15AM
Mar-30-23 01:54PM
Mar-29-23 08:15AM
07:00AM
Feb-24-23 10:00AM
Feb-08-23 08:05AM
Feb-03-23 05:00AM
(American City Business Journals)
bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases. It also offers ZYNTEGLO or beti-cel and SKYSONA or eli-cel gene therapies. The company was founded by Philippe Leboulch and Ronald C. Dorazio on April 16, 1992 and is headquartered in Somerville, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Obenshain Andrew President and CEO Mar 04 '24 Sale 1.53 6,095 9,311 279,998 Mar 05 05:40 PM Klima Thomas J See Remarks Mar 04 '24 Sale 1.53 4,573 6,986 124,840 Mar 05 05:39 PM Colvin Richard A Chief Medical Officer Mar 01 '24 Sale 1.53 6,770 10,342 118,368 Mar 05 05:40 PM Vittiglio Joseph Chief Business & Legal Officer Feb 05 '24 Sale 0.90 5,217 4,708 44,783 Feb 06 04:07 PM Klima Thomas J See Remarks Feb 05 '24 Sale 0.90 2,714 2,449 129,413 Feb 06 04:07 PM Obenshain Andrew President and CEO Feb 05 '24 Sale 0.90 1,879 1,696 286,093 Feb 06 04:07 PM Obenshain Andrew President and CEO Jan 05 '24 Sale 1.43 3,162 4,520 287,972 Jan 09 04:05 PM Colvin Richard A Chief Medical Officer Jan 05 '24 Sale 1.42 597 845 125,138 Jan 09 04:05 PM Krawtschuk Christopher Chief Financial Officer Dec 06 '23 Sale 4.52 4,526 20,437 45,474 Dec 08 04:42 PM Obenshain Andrew President and CEO Nov 03 '23 Sale 3.17 807 2,555 291,134 Nov 03 04:10 PM Colvin Richard A Chief Medical Officer Nov 02 '23 Sale 2.98 2,343 6,975 125,735 Nov 03 04:10 PM Klima Thomas J See Remarks Sep 05 '23 Sale 3.79 922 3,493 132,127 Sep 06 04:30 PM Obenshain Andrew President and CEO Aug 10 '23 Sale 3.54 16,929 59,956 291,941 Aug 10 05:00 PM Klima Thomas J See Remarks Jun 02 '23 Sale 3.50 4,130 14,451 133,049 Jun 06 04:06 PM
Index RUT P/E 15.76 EPS (ttm) 0.68 Insider Own 1.10% Shs Outstand 83.76M Perf Week -1.43%
Market Cap 893.51M Forward P/E 15.02 EPS next Y 0.71 Insider Trans -34.07% Shs Float 82.86M Perf Month -3.66%
Income 57.50M PEG 1.97 EPS next Q 0.21 Inst Own 91.26% Short Float 4.14% Perf Quarter 1.28%
Sales 2.06B P/S 0.43 EPS this Y 25.74% Inst Trans -2.30% Short Ratio 3.92 Perf Half Y 13.34%
Book/sh 7.33 P/B 1.45 EPS next Y -16.96% ROA 3.38% Short Interest 3.43M Perf Year 29.59%
Cash/sh 1.67 P/C 6.38 EPS next 5Y 8.00% ROE 9.58% 52W Range 6.71 - 11.48 Perf YTD -0.70%
Dividend Est. - P/FCF 6.39 EPS past 5Y 11.11% ROI 5.17% 52W High -7.06% Beta 1.16
Dividend TTM 0.38 (3.56%) Quick Ratio 1.05 Sales past 5Y 8.58% Gross Margin 9.49% 52W Low 58.94% ATR (14) 0.30
Dividend Ex-Date Feb 14, 2024 Current Ratio 1.86 EPS Y/Y TTM -43.57% Oper. Margin 6.06% RSI (14) 44.42 Volatility 2.92% 2.81%
Employees 871 Debt/Eq 0.82 Sales Y/Y TTM 4.60% Profit Margin 2.79% Recom 2.00 Target Price 11.50
Option/Short Yes / Yes LT Debt/Eq 0.81 EPS Q/Q 16.67% Payout 53.15% Rel Volume 0.55 Prev Close 10.76
Sales Surprise 28.10% EPS Surprise 18.52% Sales Q/Q 1.28% Earnings May 01 BMO Avg Volume 875.31K Price 10.66
SMA20 -2.59% SMA50 -2.40% SMA200 7.70% Trades
Volume 111,422 Change -0.88%
Date
Action
Analyst
Rating Change
Price Target Change
Aug-03-23 Downgrade B. Riley Securities
Buy → Neutral
$12 → $11
Feb-06-20 Initiated The Benchmark Company
Hold
Dec-05-19 Upgrade B. Riley FBR
Neutral → Buy
Sep-30-19 Downgrade B. Riley FBR
Buy → Neutral
$12 → $8
Apr-03-18 Initiated Seaport Global Securities
Buy
$13
Feb-09-18 Upgrade Clarksons Platou
Neutral → Buy
Oct-21-16 Reiterated FBR & Co.
Outperform
$9 → $11
Dec-09-15 Downgrade BofA/Merrill
Neutral → Underperform
Sep-18-15 Initiated FBR Capital
Outperform
$18
Jun-01-15 Resumed Goldman
Buy
$19
Oct-27-14 Upgrade BB&T Capital Mkts
Hold → Buy
$30
Aug-21-14 Reiterated Brean Capital
Buy
$26 → $28
Jan-31-14 Reiterated Brean Capital
Buy
$23 → $26
Oct-28-13 Reiterated Barclays
Equal Weight
$19 → $21
May-28-13 Resumed Barclays
Equal Weight
$19
Feb-02-12 Downgrade KeyBanc Capital Mkts
Buy → Hold
$15
Dec-16-11 Initiated KeyBanc Capital Mkts
Buy
$15
Dec-08-11 Initiated Oppenheimer
Outperform
$15
Aug-31-11 Initiated Barclays Capital
Overweight
$20
Show Previous Ratings
Apr-19-24 08:30AM
Apr-17-24 07:00AM
Apr-05-24 09:40AM
Apr-04-24 05:12PM
Mar-28-24 07:30AM
09:40AM
Loading…
Mar-20-24 09:40AM
Mar-14-24 07:01PM
Mar-13-24 05:00PM
Mar-12-24 09:40AM
12:11AM
Mar-04-24 11:54PM
Feb-26-24 09:40AM
Feb-22-24 05:10PM
Feb-08-24 09:40AM
Feb-02-24 08:49AM
01:04PM
Loading…
Feb-01-24 01:04PM
07:54AM
(Associated Press Finance)
07:35AM
07:30AM
Jan-18-24 07:00AM
Dec-05-23 07:00AM
Nov-20-23 09:15AM
Nov-02-23 10:19AM
12:41AM
(Thomson Reuters StreetEvents)
Nov-01-23 09:47AM
07:54AM
(Associated Press Finance)
07:30AM
07:25AM
Oct-31-23 08:40AM
Oct-18-23 07:00AM
02:58PM
Loading…
Oct-02-23 02:58PM
Sep-28-23 08:50AM
Sep-21-23 09:40AM
Sep-20-23 12:00PM
Sep-19-23 07:57AM
Sep-18-23 11:45AM
Sep-12-23 08:50AM
Sep-04-23 09:40AM
Aug-18-23 09:40AM
Aug-17-23 08:50AM
Aug-04-23 06:08AM
Aug-03-23 07:18AM
Aug-02-23 02:31AM
(Thomson Reuters StreetEvents)
Aug-01-23 08:45AM
07:41AM
07:35AM
07:30AM
Jul-28-23 12:07PM
(American City Business Journals)
Jul-20-23 07:00AM
Jun-29-23 05:00AM
Jun-28-23 11:48AM
Jun-21-23 08:00PM
03:03AM
Jun-10-23 08:54AM
May-12-23 06:07AM
May-09-23 09:40AM
May-08-23 09:23AM
May-05-23 12:11AM
(Thomson Reuters StreetEvents)
May-04-23 08:45AM
07:43AM
07:35AM
07:30AM
May-03-23 06:45PM
Apr-27-23 09:45AM
Apr-26-23 08:00PM
Apr-24-23 07:00AM
Apr-18-23 07:00AM
Apr-17-23 12:47PM
Apr-06-23 10:09AM
Apr-03-23 09:40AM
Mar-24-23 07:00AM
Mar-18-23 06:33PM
Mar-16-23 09:40AM
Feb-28-23 09:40AM
Feb-24-23 08:50AM
08:50AM
Feb-21-23 12:18PM
08:49AM
Feb-15-23 12:00PM
Feb-09-23 09:40AM
Feb-08-23 08:50AM
08:50AM
Feb-05-23 07:23AM
Feb-03-23 03:55PM
Feb-02-23 07:35AM
07:30AM
Jan-20-23 06:30AM
Jan-18-23 08:50AM
Jan-17-23 09:40AM
Jan-01-23 07:27AM
Nov-28-22 12:27PM
Nov-12-22 07:07AM
Nov-07-22 09:40AM
08:31AM
Nov-01-22 09:40AM
Oct-31-22 07:55AM
06:45AM
06:40AM
Oct-27-22 08:15AM
Oct-18-22 06:30AM
SunCoke Energy, Inc. engages in the production of coke through heating metallurgical coal in a refractory oven. It operates through the following segments: Domestic Coke, Brazil Coke, and Logistics. The Domestic Coke segment consists of the Jewell facility located in Vansant, Virginia, the Indiana Harbor facility located in East Chicago, Indiana, the Haverhill facility located in Franklin Furnace, Ohio, the Granite City facility located in Granite City, Illinois and the Middletown facility located in Middletown, Ohio. The Brazil Coke segment focuses on the operations in Vitoria, Brazil. The Logistics segment refers to the CMT, KRT, and Lake Terminal, which provide services to the Indiana Harbor coke making facility and DRT, which involves services to the Jewell coke making facility. The company was founded in December 2010 and is headquartered in Lisle, IL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Rippey Michael G Chief Executive Officer Mar 13 '24 Sale 11.06 78,714 870,577 342,359 Mar 14 03:41 PM Rippey Michael G Chief Executive Officer Mar 12 '24 Sale 11.05 100,000 1,105,000 421,073 Mar 13 02:00 PM Rippey Michael G Chief Executive Officer Mar 11 '24 Sale 11.11 122,533 1,361,342 521,073 Mar 13 02:00 PM Rippey Michael G Chief Executive Officer Mar 08 '24 Sale 10.96 22,519 246,808 643,606 Mar 11 04:53 PM Rippey Michael G Chief Executive Officer Mar 07 '24 Sale 10.92 97,284 1,062,341 666,125 Mar 11 04:53 PM Rippey Michael G Chief Executive Officer Mar 04 '24 Sale 10.93 48,618 531,395 763,409 Mar 04 06:45 PM Rippey Michael G Chief Executive Officer Mar 01 '24 Sale 10.85 1,707 18,521 812,027 Mar 04 06:45 PM Hardesty Phillip Michael Senior Vice President Feb 23 '24 Sale 10.84 4,799 52,021 217,323 Feb 27 04:21 PM Hardesty Phillip Michael Senior Vice President Aug 31 '23 Sale 9.27 16,531 153,242 182,502 Sep 01 05:51 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
